HDAC6 and glioblastoma: HDAC6 silencing decreases cell proliferation, clonogenicity, and migration in glioblastoma cell lines; restores the primary cilium, reverts the EMT phenotype, and inhibits autophagy; and also inhibits the Shh pathway in U87MG cells.